HuffPost: Does the type of soap or hand sanitizer you use matter for coronavirus?
UC expert provides information for warding off COVID-19
Dr. Carl Fichtenbaum of UC's Division of Infectious Diseases was interviewed by the Huffington Post about how coronavirus is spread for a story about proper hand sanitation.
Dr. Carl Fichtenbaum working in a lab in the Division of Infectious Diseases at UC's College of Medicine.
According to medical experts, thorough hand washing is one of the key methods of warding off COVID-19. Dr. Fichtenbaum discussed how the virus is spread and said the type of soap or sanitizer used isn't as important as proper hand washing.
“There is no clear evidence that antibacterial soap works better than any other soap,” Fichtenbaum told HuffPost. “The most important thing is washing hands for at least 20 seconds, and then it is a combination of soap plus mechanical disruption that works [to rid hands of the virus].”
Read the entire story here.
Find the latest details related to coronavirus disease 2019 (covid-19) on the Centers for Disease Control and Prevention (CDC) website, and follow UC's latest information with regard to the virus.
Related Stories
Driven by curiosity, guided by care
May 14, 2026
Max Wilson, a University of Cincinnati College of Allied Health Sciences health sciences major on the pre-physician assistant track, found his path expanding beyond the classroom and into hands-on research focused on human performance and patient care.
Is a colonoscopy painful?
May 13, 2026
The University of Cincinnati's Susan Kais, MD, assistant professor of clinical medicine in the Division of Gastroenterology and Hepatology in the College of Medicine and UC Health gastroenterologist, recently appeared on the ARC Cincinnati morning program on Local 12/WKRC-TV to answer common questions from viewers about colonoscopies and to dispel myths.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.